(Q42547225)

2 November 2017

title

In vitro antifungal activity of BMS-181184 against systemic isolates of Candida, Cryptococcus, and Blastomyces species (English)

1 reference

2 November 2017

4

1 reference

2 November 2017

Karlowsky JA

1

1 reference

2 November 2017

Zhanel GG

2

1 reference

2 November 2017

Balko TV

3

1 reference

2 November 2017

Kabani AM

5

1 reference

2 November 2017

Hoban DJ

6

1 reference

2 November 2017

publication date

1 August 1997

1 reference

Diagnostic Microbiology and Infectious Disease

2 November 2017

published in

1 reference

2 November 2017

volume

28

1 reference

2 November 2017

issue

4

1 reference

2 November 2017

page(s)

179-182

1 reference

In vitro antifungal and fungicidal spectra of a new pradimicin derivative, BMS-181184

2 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900061-8

7 January 2021

Impact of the changing epidemiology of fungal infections in the 1990s

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900061-8

7 January 2021

Studies on the mode of antifungal action of pradimicin antibiotics. II. D-mannopyranoside-binding site and calcium-binding site.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900061-8

7 January 2021

Mechanisms and clinical impact of antifungal drug resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900061-8

7 January 2021

In vitro activity of BMS-181184 compared with those of fluconazole and amphotericin B against various candida spp

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900061-8

7 January 2021

10.1016/S0732-8893(97)00061-8

Identifiers

DOI

1 reference

2 November 2017

1 reference